Web8 de mai. de 2012 · There is randomized evidence that atorvastatin at 80 mg/day provides significant reductions in the risks of cardiovascular events and stroke beyond that … Web1 de out. de 2024 · The PREVENTABLE trial is aiming to enroll 20,000 community-dwelling primary prevention patients age ≥75 and randomize individuals to atorvastatin 40 mg daily, or placebo. The primary outcomes include dementia and physical disability over 4 years.
To study the effect of high dose Atorvastatin 40 - ScienceDirect
Web20 de abr. de 2008 · Pfizer Inc announced today that Lipitor® (atorvastatin calcium) 80 mg reduced the risk of heart attack and stroke by 32 percent in patients who have heart disease and chronic kidney disease compared with patients taking the 10 mg dose of Lipitor. This analysis, designed and completed following the closure of the five-year Treating to New … WebObjectives: To study whether high-dose versus usual-dose statin treatment reduces the incidence of peripheral artery disease (PAD) and what is the effect of high-dose statin … ctrn nursing certification
High-dose atorvastatin versus moderate dose on early vascular ...
Web8 de mai. de 2012 · There is randomized evidence that atorvastatin at 80 mg/day provides significant reductions in the risks of cardiovascular events and stroke beyond that afforded by a 10-mg dose in patients with coronary disease. 1 In the Treating to New Targets (TNT) trial, high-dose atorvastatin significantly reduced total cholesterol and triglycerides … WebHigh-dose atorvastatin may produce an optimal result for STEMI patients undergoing PCI by improving microvascular myocardial perfusion. (Efficacy of High-Dose AtorvaSTATIN … Web11 de nov. de 2024 · These moderate doses of statin were shown to reduce CVD events by 30 percent . However, most trials compared a fixed dose of a single pharmacologic agent with placebo, and none of the trials have directly compared the effects of low-to-moderate- with high-intensity statin therapy. ctr no match for platform in manifest